The physicochemical properties of hydrogels can be manipulated in both space and time through the controlled application of a light beam. However, methods for hydrogel photopatterning either fail to maintain the bioactivity of fragile proteins and are thus limited to short peptides, or have been used in hydrogels that often do not support three-dimensional (3D) cell growth. Here, we show that the 3D invasion of primary human mesenchymal stem cells can be spatiotemporally controlled by micropatterning the hydrogel with desired extracellular matrix (ECM) proteins and growth factors. A peptide substrate of activated transglutaminase factor XIII (FXIIIa)-a key ECM crosslinking enzyme-is rendered photosensitive by masking its active site with a photolabile cage group. Covalent incorporation of the caged FXIIIa substrate into poly(ethylene glycol) hydrogels and subsequent laser-scanning lithography affords highly localized biomolecule tethering. This approach for the 3D manipulation of cells within gels should open up avenues for the study and manipulation of cell signalling.
S
ynthetic hydrogels have been engineered as powerful scaffolds to mimic a cell's native microenvironment to rationally control cellular behaviour in tissue engineering 1, 2 . The application of such artificial ECMs (aECMs), and in particular their fabrication with well-defined physicochemical bulk properties, has also enabled researchers to gain insights into the biology of crosstalk between cells and microenvironmental components (for example, refs [3] [4] [5] . However, the control over bulk gel properties is often not sufficient to elicit a desired morphogenetic response and to ultimately form a functional tissue de novo. In the absence of tightly orchestrated and localized morphogenetic cellular stimuli within aECMs, multicellular processes necessary for tissue formation cannot easily be induced 6 . In contrast to their engineered counterparts, natural ECMs are not homogeneous entities but rather spatially patterned milieus with a cell-type specific composition and structure that can rapidly change over time in response to the physiological demands of a tissue. For example, tissue or organ formation starts with a spatiotemporally coordinated cell polarization, and during tissue regeneration the ECM is rapidly remodelled in a highly localized and heterogeneous manner. Therefore, biomimicry strategies in tissue engineering could benefit from precise control over aECM properties in space and in time.
To this end, important progress has been made over the past few years in the design of synthetic hydrogels with biochemical and biophysical properties that can be modulated by a light beam at the micrometre scale and at a desired time during an experiment 7 . Two complementary strategies have emerged. In one approach, dynamic changes in gel properties were achieved by locally cleaving photosensitive bonds to release biochemical ligands or decrease gel crosslinking density [8] [9] [10] . This strategy was, for example, used to influence the growth of encapsulated mesenchymal progenitor cells within photopolymerized poly(ethylene glycol) (PEG) hydrogels 8 . Photodegradation thus altered gel features in a subtractive manner rather than by addition of biological signals.
Whereas native microenvironments are frequently degraded and remodelled by cellular activity (for example, during proteolysis in wound healing), locally modular microenvironments may emerge most frequently from the secretion of biological signals from a cellular source (for example, gradients of morphogens in embryonic development). Thus, as a second approach, this additive mode of local microenvironmental patterning was achieved by other groups using chemical crosslinking strategies [11] [12] [13] [14] [15] . Indeed, approaches employing radical reactions of acrylates or thiol-enes, or photoprotected thiol residues in Michael-type addition, have demonstrated successful local patterning of hydrogel matrices with simple cell-adhesion peptides 11, 12, 14 . These advances are exciting. Yet, in contrast to the relatively easy functionalization of gels with peptides, with one notable exception exploiting physical binding interactions 15 , the patterning of more complex and physiologically relevant signalling proteins has not been achieved. This is not surprising, because the activity and stability of proteins can be compromised by bioconjugation reactions that are not sufficiently mild and specific. Moreover, full-length proteins cannot be easily modified with photosensitive moieties used in existing photopatterning techniques. We consequently reasoned that enzymatic crosslinking reactions might be ideal targets for spatiotemporally controlled in situ hydrogel patterning with fragile biomolecules such as proteins. We reasoned that by masking an enzymatic peptide substrate with a photolabile cage 16 , the enzyme-mediated bioconjugation could be spatiotemporally controlled by light exposure according to the concept shown in Fig. 1 . By covalently incorporating these caged substrates into a hydrogel network (Fig. 1a) , subsequent local photoactivation (Fig. 1b) was expected to enable highly localized enzymatic biomolecule tethering (Fig. 1c) . Here we show that this concept can be successfully reduced to practice, affording exquisite control over the site-specific immobilization of virtually any desired protein within a synthetic hydrogel network. We chose a crosslinking scheme catalysed by FXIIIa, a key enzyme responsible for fibrin polymerization during blood coagulation 17, 18 , because we, inspired by pioneering work of other groups on transglutaminase-mediated crosslinking of PEG hydrogels 19, 20 , had previously used FXIIIa for hydrogel crosslinking and biomolecule functionalization 21 . FXIIIa catalyses reactions between an ε-amine of lysine (K) onto a γ-carboxamide residue of glutamine (Q), resulting in the covalent bond formation of an ε-(γ-glutamyl)lysine isopeptide. To spatiotemporally control FXIIIamediated crosslinking, we abolished the enzymatic susceptibility of one of its substrates by covalent attachment of a photolabile cage that can be reactivated after photo-illumination (Fig. 1) . The short amine donor FXIIIa substrate AcFKG, simply termed here as K-peptide, was chosen for the modification with the cage. The cage on the ε-amine of its lysine (K) was targeted to block the FXIIIa-mediated nucleophilic attack on the glutaminyl residue (Q) of the amine-acceptor peptide NQEQVSPL (termed Q-peptide). As a photosensitive caging group, we chose nitroveratryloxycarbonyl (Nvoc) to modify lysine-Fmoc ( Supplementary Fig. S1 ). In comparison with other cages that are active at lower excitation wavelengths, Nvoc has a broad absorption in ultraviolet/visible around 350 nm, which is advantageous in terms of a wider depth of uncaging penetration in tissues as well as reduced DNA and biomolecule damage 16, 22 . Thus, we reasoned that this approach would be suitable for gel applications in the presence of cells in vitro and in vivo. The photoprotection of the ε-amine residue of the K-peptide was achieved by incorporation of a photoprotected lysine derivative during solid-phase peptide synthesis as described in the Supplementary Information.
We first assessed the feasibility of light-controlled enzymatic crosslinking by way of using a soluble model system (Fig. 2) . When tested on high-pressure reverse-phase high-performance liquid chromatography (RP-HPLC) with an analytical C 18 -column, the caged lysine-containing peptide [1 ] was shown to elute at a different retention time (t R ) from the unmodified substrate [1] (Fig. 2a) . Notably, two peaks corresponding to the caged product appeared after peptide purification performed by a semipreparative C 18 -column. As both peaks corresponded to the same mass ( Supplementary Fig. S2 ) and had similar ultraviolet spectra (210-400 nm; Supplementary Fig. S3 ), it is very likely that they represent a different conformation of the same peptide. Importantly, when the caged peptide in solution was exposed to ultraviolet light from a mercury lamp, a new product was observed, corresponding to the unprotected FXIIIa substrate [1] . A variation of exposure times allowed us to quantify uncaging efficiencies by HPLC (Fig. 2a, inset) . Accordingly, photolysis proceeded with first-order kinetics until a plateau was reached near completion after about 20 s (Fig. 2a, inset) . The half-life of photolysis was calculated by linear regression to be t 1/2 = 10.5 s (Supplementary Fig. S4 ).
To investigate FXIIIa-mediated crosslinking after uncaging, we incubated the caged K-peptide [1 ] together with the counterreactive Q-peptide [2] and FXIIIa to induce crosslinking (Fig. 2b) . As expected, analytical HPLC analysis clearly indicated that the caged substrate was unable to undergo crosslinking, which occurred with unmodified substrate at t R = 7.7 min. However, light exposure of the caged K-peptide [1 ] in the presence of equimolar amounts of Q-peptide [2] and FXIIIa resulted in the crosslinked product [3] (t R = 9.5 min), providing important first evidence for lightactivated, enzymatic bond formation in this soluble model system.
In a next set of experiments we tested the light-triggered enzymatic functionalization of a synthetic hydrogel with a fluorescently labelled model Q-peptide (Fig. 3 ). The caged substrate was covalently incorporated into PEG networks by Michael-type addition of cysteine at the C terminus of the peptide with vinylsulphone groups on PEG macromers 23 . A confocal laser scanning microscope, equipped with a software-controlled positioning system of 
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following 40 s photolysis exposure to light from an ultraviolet mercury lamp followed by HPLC analyses of the generated products. Calculated half-lives of uncaging (t 1/2 ; inset, right panel). b, HPLC analyses of FXIIIa-catalysed reactions in the presence of its counter-reactive substrate. Wild-type Q-peptide [2] crosslinked with K-peptide forms product [3] (positive control), whereas in the case of the caged K-peptide [1 ] no crosslinking is detected. In contrast, exposure of the caged substrate [1 ] to an ultraviolet mercury lamp results in complete photolysis (disappearance of [1 ] ) and reactivation of the FXIIIa-catalysed crosslinking reaction (isopeptide product [3] ), proving that the concept outlined in Fig. 1 can be implemented.
an ultraviolet laser (405 nm), was used to create custom-made, spatially defined regions of interest (ROIs) of laser illumination. In the laser-exposed areas, the photolabile group was released to render the newly uncaged ε-amine group susceptible to FXIIIamediated crosslinking (Fig. 3a) . Interestingly, the release of the cage could be followed in situ by confocal microscopy ( Supplementary  Fig. S5 ), a phenomenon that could be exploited to determine the efficiency of photolysis. To allow site-selective bioconjugation, the hydrogel films were immersed in a solution containing FXIIIa and the fluorescently labelled model Q-peptide. After washing, micrometre-scale fluorescent patterns of very high spatial fidelity were clearly visible (Fig. 3b) . The patterns were detectable through the entire thickness of the thin hydrogel layer; that is, patterning occurs in three dimensions and not just on the gel surface ( Supplementary Fig. S6 ). Of note, FXIII-mediated patterning can also be performed in the presence of serum, albeit with lower efficiency (Supplementary Fig. S7 ). Software-controlled positioning of the laser-beam enabled the patterning of any shape. Moreover, the discrete change of laser intensities in the form of aligned adjacent rectangular ROIs of interest allowed the generation of user-defined biomolecule gradients within hydrogels, in either a step-wise (Fig. 3c) or a continuous (Fig. 3d) fashion.
We next sought to demonstrate the applicability of our approach to pattern biomolecules within gels by way of a biologically relevant example, namely the morphogen vascular endothelial growth factor 121 (VEGF 121 ; Fig. 3e , left panel) and the recombinant fibronectin type III repeat 9-10 fragment of fibronectin 24 (FN 9−10 ; Supplementary Fig. S8 ). Indeed, because the activity and stability of proteins can be easily compromised by crosslinking reactions that are not highly site-specific, most previous approaches in hydrogel photopatterning by biomolecules were limited to short oligopeptides such as the minimal integrin-binding ligand RGD (refs 11,12,14) . These signals can be readily modified to have photoreactive groups, which is not the case for full-length proteins. We used recombinant VEGF 121 engineered with an exogenous Q-peptide domain at the N terminus to enable enzymatic crosslinking 25 . On localized uncaging of the tethered caged Kpeptide, hydrogel films were immersed in FXIIIa-containing buffer together with VEGF 121 . Visualization of laser-patterned areas by immunostaining showed clearly visible and specific VEGF 121 patterns of high fidelity (Fig. 3e) .
To determine whether the bioactivity of VEGF 121 could be altered on FXIIIa-mediated tethering to PEG, we used PEGconjugated VEGF 121 as a soluble model system. To this end, VEGF 121 was modified with PEG monomethyl ether (mPEG; 5 kDa) either through site-specific catalysis, or through nonspecific chemical crosslinking using an amine-reactive mPEG succinimidyl ester ( Supplementary Fig. S9 ). Using a HUVEC proliferation assay 25 , we compared the mitogenic activity of both PEG-VEGF 121 constructs to native VEGF 121 . At a relatively low (that is, nonsaturating) concentration of 5 ng ml −1 , a significant reduction in the activity was found for nonspecifically coupled PEG-VEGF 121 , in contrast to the site-specifically modified version ( Supplementary  Fig. S10 ), although the bioactivity of the two PEGylated proteins was not found to be statistically significant. Nevertheless, these data indeed suggest a good preservation of bioactivity for the FXIIIa-mediated tethering of proteins in our PEG hydrogel system.
We next used an enzyme-linked immunosorbent assay to determine the overall concentration of covalently incorporated VEGF 121 in matrix metalloproteinase (MMP)-sensitive PEG hydrogels 23 containing 1 mM K-peptide (see Supplementary Information for experimental details). FXIIIa-mediated tethering of 20 ng ml −1 (1.25 nM) VEGF 121 resulted in 4.93 ng ml −1 (0.31 nM or 24.6% of total amount) of immobilized VEGF 121 in these gels ( Supplementary  Fig. S11 ). Furthermore, confocal microscopy imaging of fluorescent VEGF 121 revealed a relatively rapid decrease of the protein intensity within increasing penetration depth to circa 500 µm (Supplementary Fig. S12 ), suggesting that enzyme diffusion is the limiting parameter for protein coupling. Assuming a linear correlation of the VEGF 121 concentration with fluorescent intensity, we calculated the concentration profile across the entire thickness of the gel (Supplementary Fig. S13 ). On the basis of this profile and the total amount of incorporated VEGF 121 determined by enzyme-linked immunosorbent assay, we obtain for the given initial concentration in the labelling solution a maximal concentration of 0.26 ng ml To broaden the applicability of our patterning platform to any type of signalling protein in a generic and more widely accessible fashion, we immobilized proteins in hydrogels through binding to ProteinA (and ProteinG, not shown; Fig. 3f ). ProteinA contains five high-affinity binding sites (K a = 10 8 per mole) for the Fc-region of human, mouse and rabbit immunoglobulins, and thus allows for easy, site-selective immobilization of Fc-tagged proteins 4 , many of which are commercially available. To this end, we modified ProteinA with caged Q-peptides and enzymatically patterned it within hydrogels. Indeed, the spatially controlled distribution of ProteinA nicely translates into specific patterns of Fc-tagged proteins as exemplified here by binding of Alexa488-modified IgG (Fig. 3f, left panel) . Importantly, in the absence of ProteinA, no IgG binding was observed (Fig. 3f, right panel) .
Finally, we sought to exploit light-activated enzymatic gel patterning for manipulating the behaviour of live cells directly in culture. As a physiologically relevant model system, we chose to control the 3D invasion of human mesenchymal stem/progenitor cells (termed mesenchymal stem cells (MSCs) herein; Fig. 4) . MSCs are well known to migrate towards inflamed sites in tissues and are considered as key components of the complex microenvironment contributing to cancer maintenance and dissemination 26 . To modulate in situ and in three dimensions the direction of MSC invasion, we patterned the fibronectin-derived adhesion peptide RGD, the recombinant fibronectin fragment FN 9−10 (ref. 24) , and platelet-derived growth factor B (here, PDGF-BB; ref. 27) , each engineered to comprise a Q-peptide. These biomolecules were selected because they play a role during MSC invasion [28] [29] [30] and because our MSCs express high levels of receptors for these signals (not shown). Multicellular clusters (microtissues) assembled from MSCs were incorporated into MMP-sensitive PEG hydrogels 23 bearing tethered caged K-peptide (Fig. 4a) . On local uncaging of cuboidal patterns on one hemisphere of the microtissues, fluorescently labelled RGD and FN 9−10 were enzymatically immobilized within gels, as shown for example in Fig. 4b . Strikingly, MSCs invade exclusively within patterned gel regions containing RGD (Fig. 4b,c and Supplementary Movie S1) or FN 9−10 (Fig. 4d) . In both cases, the differences between patterned and unpatterned regions are highly significant (p < 0.01) (Fig. 4c,d, right panels) . Confocal imaging demonstrates invasion in three dimensions to a depth of approximately 300 µm (Fig. 4c,d, left panel) , consistent with the VEGF 121 concentration profile determined above ( Supplementary  Fig. S13) . Notably, the patterning of PDGF-BB in cell-adhesive and MMP-sensitive gels also resulted in significantly (p < 0.05) higher invasion in patterned regions (Fig. 4e) . Therefore, light-activated enzymatic gel patterning can be exploited for manipulating the behaviour of live cells in three dimensions directly in culture.
Our experiments highlight that site-specific tethering of fragile proteins, such as adhesion proteins and growth factors, within gels by localized, laser-assisted uncaging is indeed feasible. Using a generic protein binding strategy, our method can be applied to virtually any kind of protein, and makes it a powerful alternative to selectively blocking the active site of biomolecules by photolabile groups 31, 32 . The latter approach is straightforward for peptides but cumbersome in the case of full-length proteins. The automated xyzpositioning of the laser allows biomolecule patterning within gels with unprecedented flexibility and fidelity; the design of the patterns is indeed limited only by the user's imagination. We envision that this system could serve as a powerful tool in tissue engineering and cell biology to address questions related to spatiotemporal signalling of biomolecules such as morphogens. As one exciting example, the recapitulation of morphogen gradients within 3D structures and an investigation into their influence on the fate of developing pluripotent stem cells is conceivable.
Methods
Synthesis of caged peptide. Caged Fmoc-lysine (N α-Fmoc-N ε-Nvoc-lysine) ( Supplementary Fig. S1 ) for standard Fmoc solid-phase peptide synthesis was synthesized following published protocols 33 .
Photolysis reactions of caged peptide performed in solution. 100 µl of a 400 µM stock solution of caged K-peptide in water and 0.04% dimethylsulphoxide (in a quartz cuvette) were exposed to the light of a Hg lamp (100 W) at a distance of 25 cm. FXIIIa-mediated crosslinking in solution. FXIIIa was used at 1 U ml −1 for enzyme-catalysed crosslinking of the two substrates AcFKGGERCG-NH 2 (100 µM) and NQEQVSPLERCG-NH 2 (100 µM) in 100 µl of reaction buffer containing 50 mM CaCl 2 , 50 mM Tris at pH 7.6 and 1 mM dithiothreitol. Reactions were conducted for 45 min at room temperature and stopped by the addition of 50 µl 0.1% trifluoroacetic acid in H 2 O, and kept on ice before performing analytical RP-HPLC (C 18 -column, Symmetry, Waters).
Preparation of thin PEG hydrogel films. PEG hydrogels (5% w/v) were prepared by Michael-type addition from two aqueous precursors containing 8arm-PEG-vinylsulphone and 4arm-PEG-thiol (ref. 34) . Gelation was performed in 0.3 M HEPES at pH 7.9 at 37 • C for 20 min. Incorporation of 1 mM caged K-peptide through thiols of its cysteine residue rendered hydrogels photosensitive. Hydrogels were cast between 3-mercaptopropyl-trimethoxylsilane-treated glass slides and hydrophobic, siliconized glass slides (Sigmacote, SL-2) using 100 µm spacers. The obtained thin hydrogel layers were immersed in water to allow overnight swelling at 4 • C.
Laser-assisted hydrogel patterning. An upright point-scanning confocal microscope (Zeiss, 710 LSM) equipped with a 405 nm diode laser (30 mW) and with W N-Achroplan ×20/0.5 or EC Plan-Neofluar ×10/0.30 objectives was employed for local illumination of gels. The bleaching mode and user-defined ROI scanning option of the microscope software (ZEN2009) allowed precisely controlled arbitrary patterns in xyz. Precise control of specific laser intensities assigned to each ROI allowed the generation of biochemical gradients. For example, step-wise gradients were obtained by aligning seven contacting rectangular ROIs (100 µm width), each of which had assigned a different assigned laser intensity (100-80-60-40-20-10-5% of the maximal laser power). The time of laser irradiation was approximately 2.5 min, equal to the sum of 100 iterations of laser scanning. Continuous gradients were obtained by decreasing the laser power (18-5% of the maximal power) and by choosing smaller patterns (rectangles of 25 µm in width). In this case, the time of laser irradiation was approximately 1.5 min, equal to the sum of 200 iterations of laser scanning.
FXIIIa-mediated biomolecule tethering to hydrogels in two dimensions.
Laser-treated hydrogels were immersed in FXIIIa-labelling solution (5 U ml −1 FXIIIa, 50 mM CaCl 2 , 150 mM NaCl, and 50 mM Tris at pH 7.6) with a protein of interest bearing a FXIII substrate. To fluorescently visualize local FXIIIa-catalysed crosslinking, the Q-peptide was functionalized with a maleimide-functionalized Alexa Fluor dye (A-20347, Invitrogen) through its cysteine side chain thiol. FXIIIa-mediated fluorescent patterns were obtained on reaction with 150 µM fluorescent Q-peptide for 45 min at room temperature. The crosslinking reaction was stopped by adding washing buffer (100 mM NaCl and 50 mM Tris buffer, at pH 7.6). Fluorescent patterns were visible after about 30 min of washing, the time necessary for sufficient diffusion of non-bound fluorescent peptide. Fluorescent microscopy images were acquired after overnight washing at 4 • C to ensure complete diffusion of the soluble fluorescent peptide.
VEGF patterning. FXIIIa-catalysed patterning of a VEGF 121 variant comprising an exogenous Q-peptide was performed as described above. VEGF 121 (5.4 µg in 30 µl) of FXIIIa labelling solution was added to the laser-exposed hydrogels and left for 45 min at room temperature. After overnight washing in washing buffer at 4 • C, VEGF patterns were visualized by immunostaining with a VEGF-specific primary antibody (rabbit polyclonal VEGF, A-20, sc-152, Santa Cruz Biotechnology) followed by exposure to an Alexa Fluor 647 goat antirabbit secondary antibody (A-21245, Invitrogen). Fluorescent microscopy images were acquired after two hours of washing in PBS with 0.1% Tween.
ProteinA patterning. Gel modification by ProteinA was achieved in two steps comprising functionalization of ProteinA with maleimide groups by reacting it with a heterobifunctional PEG linker (NHS-PEG-maleimide, 5 molar excess), followed by attachment of the Q-peptide through its free thiol. The obtained Q-peptide-modified ProteinA (19.6 µg) was added to 30 µl FXIIIa reaction buffer for subsequent ProteinA immobilization on the laser-activated hydrogel. The reaction was conducted as described above. Control hydrogels were treated in the same manner except for the addition of ProteinA to FXIIIa reaction buffer. The patterns of tethered ProteinA were visualized by immunostaining with an Alexa Fluor 488 rabbit secondary antibody (A-11078, Invitrogen).
MSC culture and multicellular spheroid formation. MSCs previously isolated from human placenta 35 were cultured in DMEM with Glutamax supplemented with 1 mM sodium pyruvate, HEPES at pH 7.5, 5% penicillin/streptomycin and 10% fetal calf serum. Cells were used between passages 7 and 16. Multicellular spheroids were formed from 15 × 10 3 cells ml −1 using a hanging-drop technique (30 µl droplets) in serum-free DMEM with 20% methocel derived from methyl cellulose (Sigma) as described previously 36 . Spheroids were collected after overnight incubation and washed once in serum-free DMEM medium.
Preparation of PEG hydrogels for 3D cell culture. MMP-sensitive PEG hydrogels were formed as described previously 23 through Michael-type addition from two aqueous precursors containing 4arm-PEG-vinylsulphone (20 kDa) and the MMP substrate peptide GCRDGPQG↓IWGQDRCG (↓ indicates cleavage site, MW 1773 g mol −1 ) at equimolar ratio and a final concentration of 3.4% (w/v). Gelation was performed in the presence of MSC spheroids in 0.1 M HEPES at pH 7.9 and 13% medium at 37 • C for 35 min. Caged K-peptide (1 mM) was incorporated in hydrogels. Gels (10 µl precursor solutions) were cast on µ-slide angiogenesis (ibidi, Germany). The obtained thin hydrogel layers were immersed in medium to swell to equilibrium at 37 • C.
FXIIIa-mediated biomolecule tethering to hydrogels in three dimensions. Laser-treated hydrogels were immersed for 90 min in FXIIIa-labelling solution (2 U ml −1 FXIIIa, 10 mM CaCl 2 , 10 mM HEPES at pH 7.5 in serum-free DMEM medium) with peptides or recombinant proteins containing the exogenous FXIIIa substrate NQEQVSPL as a Q-peptide at the N terminus. The crosslinking reaction was stopped by washing with PBS followed by serum-free DMEM for several minutes. This procedure was repeated twice with subsequent overnight washing at 37 • C and 5% CO 2 .
3D MSC invasion in patterned hydrogels. The Q-peptide-modified RGD peptide NQEQVSPL-RGDSPERCG was functionalized with a maleimide-functionalized Alexa Fluor 488 (A-10254, Invitrogen), and 150 µM of the peptide was added to the labelling solution and immobilized as described above. After overnight washing, hydrogels were immersed in DMEM supplemented with serum and 100 ng ml −1 recombinant human PDGF-BB (PreproTech) to stimulate cell migration. The same procedures were used for the recombinant fibronectin type III repeat 9-10 fragment (specifically referred to elsewhere as FNIII9*-10; ref. 24) (21 kDa, 130 µM) and a recombinant PDGF-BB variant (20 ng ml −1 ) bearing exogenous Q-peptides (production described in Supplementary Information). In the latter case, hydrogels were rendered cell-adhesive by conjugating 30 µM RGD and were cultured in serum-free DMEM without PDGF supplement. Cells were fixed with 4% PFA, stained with 4 ,6-diamidino-2-phenylindole (DAPI) and visualized with confocal and bright-field microscopy. Quantification was performed using Fiji and Imaris software.
